替泽帕肽

替泽帕肽（CAS 2023788-19-2）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

Tirzepatide is an agonist of the receptors of two insulin sensitizing polypeptides, GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide 1), that is used as therapy of type 2 diabetes, obstructive sleep apnea, and obesity. Tirzepatide has been linked to minimal instances of elevations in serum aminotransferase levels during therapy and rare episodes of clinically apparent liver injury.Breast Feeding; Lactation; Milk, Human; Hypoglycemic Agents; Incretins; Glucagon-Like Peptide-1 Agonists; GLP-1 Agonists

同义词与商品名

Zepbound; tirzepatida; tirzepatidum; OYN3CCI6QE; RefChem:58651; BG-121; GTPL11429; FT181880; FT182420; Tirzepatide sodium salt (LY3298176)?

GHS 危害分类

Reported hazard statements	H302, H312, H332 (50%), H315 (50%), H319 (50%)

H302+H312+H332 (50%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]

H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]

公开数据库对它的描述

Tirzepatide · CAS 2023788-19-2 · C225H348N48O68. UNII OYN3CCI6QE. Solubility: <1 mg/mL.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。